Bristol Agrees To One-Month Inventory Limit Under SEC Settlement
This article was originally published in The Pink Sheet Daily
Executive Summary
Settlement marks first definition of "normal" inventory levels for pharmaceutical industry. Bristol agrees to $150 mil. civil penalty to resolve investigation into "channel stuffing" during 2000-2001.
You may also be interested in...
Bristol Settles DoJ "Channel Stuffing" Investigation For $300 Mil.
The company will take a $249 mil. charge in the second quarter, in addition to a first quarter charge of $51 mil. The monies will be added to a shareholder fund created under a separate, earlier settlement with SEC. CEO Dolan loses his chairman's title under the pact, and Bristol agrees to cooperate with investigations of former executives.
Bristol Settles DoJ "Channel Stuffing" Investigation For $300 Mil.
The company will take a $249 mil. charge in the second quarter, in addition to a first quarter charge of $51 mil. The monies will be added to a shareholder fund created under a separate, earlier settlement with SEC. CEO Dolan loses his chairman's title under the pact, and Bristol agrees to cooperate with investigations of former executives.
Bristol Increases Reserves In Anticipation Of Further SEC Action
The company has set aside $140 mil. as its minimum estimated liability from ongoing investigations into accounting issues. Bristol already paid $150 mil. to settle civil claims filed by SEC.